Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein K pseudogene 1 (HNRNPKP1) is classified as a processed pseudogene, meaning it is a non-functional genomic DNA sequence that resembles the functional HNRNPK gene but does not encode an active protein[1][3][5]. Pseudogenes like HNRNPKP1 typically arise through gene duplication or retrotransposition events and generally do not produce functional proteins or have direct biological activity. There is no current evidence supporting HNRNPKP1 as a therapeutic target, nor is it implicated in disease mechanisms, drug interactions, or biomarker roles. All major databases classify this entry as a non-functional pseudogene, not an active gene product or protein[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein K pseudogene 1 (HNRNPKP1).